Bioconjugate Chemistry · 2015 · 91 citations · 21 references
PharmacyOncologyPharmaceuticsDrug DeliveryMolecular ImagingMolecular OncologyCancer Cell SignalingExtracellular MatrixPeptide DeliveryPeptide Drug DiscoveryProstate Cancer ImagingTargeted Cancer TherapyEpithelial-mesenchymal Transition MarkersFibronectin BindingFluorescent Probe DesignGleason ScoringMolecular Target ImagingPeptide Targeting LigandsPeptide-based TargetingTumor-targeting Peptides
Extradomain-B fibronectin (EDB-FN), one of the oncofetal fibronectin (onfFN) isoforms, is a high-molecular-weight glycoprotein that mediates cell adhesion and migration. The expression of EDB-FN is associated with a number of cancer-related biological processes such as tumorigenesis, angiogenesis, and epithelial-to-mesenchymal transition (EMT). Here, we report the development of a small peptide specific to EDB-FN for targeting prostate cancer. A cyclic nonapeptide, CTVRTSADC (ZD2), was identified using peptide phage display. A ZD2-Cy5 conjugate was synthesized to accomplish molecular imaging of prostate cancer in vitro and in vivo. ZD2-Cy5 demonstrated effective binding to up-regulated EDB-FN secreted by TGF-β-induced PC3 cancer cells following EMT. Following intravenous injections, the targeted fluorescent probe specifically bound to and delineated PC3-GFP prostate tumors in nude mice bearing the tumor xenografts. ZD2-Cy5 also showed stronger binding to human prostate tumor specimens with a higher Gleason score (GS9) compared to those with a lower score (GS 7), with no binding in benign prostatic hyperplasia (BPH). Thus, the ZD2 peptide is a promising strategy for molecular imaging and targeted therapy of prostate cancer.
21
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
Delineation of prognostic biomarkers in prostate cancer
Saravana M. Dhanasekaran, Terrence R. Barrette, Debashis Ghosh et al. · Nature · 2001 · 1.7K citations · Full text